| Descriptor English: | HIV Envelope Protein gp41 | ||||||
| Descriptor Spanish: |
Proteína gp41 de Envoltorio del VIH
| ||||||
| Descriptor Portuguese: | Proteína gp41 do Envelope de HIV | ||||||
| Descriptor French: | Protéine d'enveloppe gp41 du VIH | ||||||
| Entry term(s): |
Envelope Protein gp41, HIV HIV Transmembrane Protein gp41 HTLV-III gp41 env Protein gp41, HIV gp41 Envelope Protein, HIV gp41(HIV) |
||||||
| Tree number(s): |
D12.776.543.512.500.330 D12.776.964.350.520.330 D12.776.964.775.325.164.200 D12.776.964.775.562.500.200 D12.776.964.970.880.325.164.200 D12.776.964.970.880.910.330 D23.050.327.520.330 |
||||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D015700 | ||||||
| Scope note: | Transmembrane envelope protein of the HUMAN IMMUNODEFICIENCY VIRUS which is encoded by the HIV env gene. It has a molecular weight of 41,000 and is glycosylated. The N-terminal part of gp41 is thought to be involved in CELL FUSION with the CD4 ANTIGENS of T4 LYMPHOCYTES, leading to syncytial formation. Gp41 is one of the most common HIV antigens detected by IMMUNOBLOTTING. |
||||||
| Allowable Qualifiers: |
AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DE drug effects DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UL ultrastructure UR urine |
||||||
| Previous Indexing: |
Retroviridae Proteins (1986-1989) Viral Envelope Proteins (1983-1989) |
||||||
| Public MeSH Note: | 90 |
||||||
| History Note: | 90 |
||||||
| DeCS ID: | 24716 | ||||||
| Unique ID: | D015700 | ||||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
| Date Established: | 1990/01/01 | ||||||
| Date of Entry: | 1989/06/19 | ||||||
| Revision Date: | 2007/07/09 |
-
-
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Biological Factors [D23]Biological Factors
|
|
HIV Envelope Protein gp41
- Preferred
| Concept UI |
M0024085 |
| Scope note | Transmembrane envelope protein of the HUMAN IMMUNODEFICIENCY VIRUS which is encoded by the HIV env gene. It has a molecular weight of 41,000 and is glycosylated. The N-terminal part of gp41 is thought to be involved in CELL FUSION with the CD4 ANTIGENS of T4 LYMPHOCYTES, leading to syncytial formation. Gp41 is one of the most common HIV antigens detected by IMMUNOBLOTTING. |
| Preferred term | HIV Envelope Protein gp41 |
| Entry term(s) |
Envelope Protein gp41, HIV HIV Transmembrane Protein gp41 HTLV-III gp41 env Protein gp41, HIV gp41 Envelope Protein, HIV gp41(HIV) |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey
